Cargando…
“Include me if you can”—reasons for low enrollment of pediatric patients in a psychopharmacological trial
BACKGROUND: Low recruitment in clinical trials is a common and costly problem which undermines medical research. This study aimed to investigate the challenges faced in recruiting children and adolescents with obsessive-compulsive disorder and autism spectrum disorder for a randomized, double-blind,...
Autores principales: | Niemeyer, Larissa, Mechler, Konstantin, Buitelaar, Jan, Durston, Sarah, Gooskens, Bram, Oranje, Bob, Banaschewski, Tobias, Dittmann, Ralf W., Häge, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923624/ https://www.ncbi.nlm.nih.gov/pubmed/33648579 http://dx.doi.org/10.1186/s13063-021-05119-6 |
Ejemplares similares
-
Memantine as treatment for compulsivity in child and adolescent psychiatry: Descriptive findings from an incompleted randomized, double-blind, placebo-controlled trial
por: Niemeyer, Larissa, et al.
Publicado: (2022) -
Developmental changes in fronto-striatal glutamate and their association with functioning during inhibitory control in autism spectrum disorder and obsessive compulsive disorder
por: Hollestein, Viola, et al.
Publicado: (2021) -
No evidence of differences in cognitive control in children with autism spectrum disorder or obsessive-compulsive disorder: An fMRI study
por: Gooskens, Bram, et al.
Publicado: (2018) -
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial
por: Häge, Alexander, et al.
Publicado: (2016) -
Psychopharmacology
Publicado: (1989)